Prospective study including patients submitted to RYGB (n=94) and L-RYGB (n=94) at a single institution. The aim was to compare the effect on comorbidities and weight loss of a long biliopancreatic limb Roux-en-Y gastric bypass (L-RYGB), compared with a standard RYGB. Procedure selection was randomly assigned (1:1), and surgeries were performed, during 24 months (2016-2017). Weight loss, comorbidities control and nutritional status were assessed at baseline and 12 months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
192
Long biliopancreatic limb Roux-en-Y gastric bypass.
Standard Roux-en-Y gastric bypass
Hospital General Tlahuac
Mexico City, Mexico
Weight loss
Measures: Weight in kilograms
Time frame: 12 months
Weight loss
Measures: Body Mass Index
Time frame: 12 months
Weight loss
Measures: Percent of excess weight loss
Time frame: 12 months
Weight loss
Measures: Percent of total weight loss
Time frame: 12 months
Complete Diabetes Remission Rate
Measures: No need for anti-diabetics while on glucose \<100 mg/dl and HbA1c% \<6
Time frame: 12 months
Major early complications
Measure: Rate of re-operations and re-admissions
Time frame: First 30 days
Major late complications
Measure: Rate of re-operations and re-admisions
Time frame: 2-12 months
Nutritional status
Measure: serum albumin (gr/dL)
Time frame: 12 months
Nutritional status
Measure: serum total proteins (gr/dL)
Time frame: 12 months
Nutritional status
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Measure: hemoglobin (g/dL)
Time frame: 12 months